Market Overview

Morning Market Movers

Related RVNC
Morning Market Losers
Revance Therapeutics Provides Update On RT001 Clinical Program For The Lead Indication For Crow's Feet Lines
Related IIN
Morning Market Losers
Stocks Hitting 52-Week Highs

Revance Therapeutics (NASDAQ: RVNC) shares gained 21.91% to $34.89 after the company reported positive results from the RT002 Phase 1/2 study in glabellar (frown) lines.

Intricon (NASDAQ: IIN) shares jumped 18.30% to $5.50 after the company reported Q1 results.

Centene (NYSE: CNC) jumped 15.83% to $66.36 on upbeat quarterly results. Centene reported its Q1 earnings of $0.57 per share on revenue of $3.46 billion.

Allergan (NYSE: AGN) jumped 15.67% to $164.25 on buyout offer.

AxoGen (NASDAQ: AXGN) climbed 14.29% to $3.20. AxoGen is expected to report its Q1 financial results on April 30, 2014.

Dyax (NASDAQ: DYAX) surged 12.64% to $7.55. Dyax is expected to report its Q1 results on April 30, 2014.

Rent-A-Center (NASDAQ: RCII) surged 9.82% to $28.30 after the company reported upbeat quarterly earnings and issued a strong FY14 earnings forecast.

Evoke Pharma (NASDAQ: EVOK) shares rose 9.41% to $8.60 after the company initiated Phase 3 clinical trial of EVK-001 for the treatment of gastroparesis. Laidlaw & Co. initiated coverage on the stock with a Buy rating.

Netflix (NASDAQ: NFLX) shares rose 9.07% to $380.11 after the company reported better-than-expected first-quarter earnings and issued a strong outlook. Netflix reported its quarterly earnings of $0.86 per share on revenue of $1.27 billion. However, analysts were expecting earnings of $0.81 per share on revenue of $1.27 billion. Raymond James upgraded Netflix from Market Perform to Outperform.

Harley-Davidson (NYSE: HOG) gained 7.39% to $72.53 after the company reported upbeat first-quarter earnings. Harley-Davidson's quarterly earnings surged to $265.9 million, or $1.21 per share, from $224.1 million, or $0.99 per share, in the year-ago quarter.

Valeant Pharmaceuticals International (NYSE: VRX) shares climbed 5.27% to $132.65 after the company proposed to combine with Allergan (NYSE: AGN) for $48.30 per share in cash and 0.83 shares of Valeant common stock.

Intuitive Surgical (NASDAQ: ISRG) rose 4.59% to $429.99 after the company announced the FDA clearance of da Vinci(R) Sp(TM) Surgical System.

Posted-In: market moversNews Intraday Update Markets Movers

 

Related Articles (AGN + AXGN)

Around the Web, We're Loving...

Get Benzinga's Newsletters